Quantum BioPharma Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Quantum BioPharma has a total shareholder equity of $10.2M and total debt of $615.6K, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are $15.2M and $5.0M respectively.
Belangrijke informatie
6.0%
Verhouding schuld/eigen vermogen
US$615.56k
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$3.33m |
| Aandelen | US$10.20m |
| Totaal verplichtingen | US$5.04m |
| Totaal activa | US$15.25m |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 0K91's short term assets ($10.0M) exceed its short term liabilities ($5.0M).
Langlopende schulden: 0K91 has no long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 0K91 has more cash than its total debt.
Schuld verminderen: 0K91's debt to equity ratio has increased from 2.9% to 6% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: 0K91 has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Voorspelling contante baan: 0K91 is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.